| Today's Open | $19.00 |
|---|---|
| Previous Close | $18.92 |
| Daily Range | $18.32 - $19.25 |
| 52-Week Range | $1.42 - $20.09 |
| Market Cap | $1.6B |
| P/E Ratio | -55.65 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,487,411 |
| Average Daily Volume | 3,764,440 |
| Current FY EPS | -$0.35 |
Sector
Healthcare
Industry
Drugs
ACADIA Pharmaceuticals, Inc. (ACAD) Description
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/
News & Commentary
ACADIA Issues Multiple Presentations of Data from Trial of Pimavanserin, Says Long-Term Usage Safe,
ACADIA Issues Multiple Presentations of Data from Trial of Pimavanserin, Says Long-Term Usage Safe, Well Tolerated3 Humongous Health-Care Stocks This Week
Summer is still a few weeks away, but these biotech stocks already delivered sizzling heat in the first week of June.ACAD's Top Competitors
(-2.59%)
(2.44%)
(1.78%)
(1.47%)